Israel Englander’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $110M | Sell |
581,913
-720,732
| -55% | -$136M | 0.04% | 468 |
|
|
2026
Q1 | $257M | Buy |
1,302,645
+104,173
| +9% | +$20.1M | 0.11% | 162 |
|
|
2025
Q4 | $220M | Buy |
1,198,472
+84,799
| +8% | +$14.9M | 0.09% | 175 |
|
|
2025
Q3 | $171M | Buy |
1,113,673
+541,445
| +95% | +$81.9M | 0.07% | 230 |
|
|
2025
Q2 | $80M | Buy |
572,228
+96,610
| +20% | +$13.5M | 0.04% | 529 |
|
|
2025
Q1 | $69.9M | Sell |
475,618
-973,345
| -67% | -$141M | 0.04% | 556 |
|
|
2024
Q4 | $190M | Buy |
1,448,963
+1,389,725
| +2,346% | +$195M | 0.09% | 176 |
|
|
2024
Q3 | $9.23M | Buy |
59,238
+42,914
| +263% | +$6.93M | ﹤0.01% | 2245 |
|
|
2024
Q2 | $2.55M | Sell |
16,324
-1,430,231
| -99% | -$215M | ﹤0.01% | 3318 |
|
|
2024
Q1 | $196M | Buy |
1,446,555
+1,140,021
| +372% | +$151M | 0.08% | 211 |
|
|
2023
Q4 | $41.3M | Buy |
306,534
+287,333
| +1,496% | +$37.4M | 0.02% | 934 |
|
|
2023
Q3 | $2.6M | Sell |
19,201
-184,502
| -91% | -$25.2M | ﹤0.01% | 3312 |
|
|
2023
Q2 | $29.2M | Buy |
203,703
+202,175
| +13,231% | +$29.7M | 0.01% | 1093 |
|
|
2023
Q1 | $212K | Sell |
1,528
-314,003
| -100% | -$42.2M | ﹤0.01% | 5134 |
|
|
2022
Q4 | $42.8M | Sell |
315,531
-399,900
| -56% | -$50.2M | 0.02% | 853 |
|
|
2022
Q3 | $78.5M | Buy |
715,431
+135,545
| +23% | +$17.2M | 0.05% | 455 |
|
|
2022
Q2 | $76.6M | Buy |
579,886
+403,983
| +230% | +$53M | 0.05% | 417 |
|
|
2022
Q1 | $23.3M | Sell |
175,903
-190,054
| -52% | -$22.8M | 0.01% | 1231 |
|
|
2021
Q4 | $42.6M | Buy |
365,957
+106,471
| +41% | +$12.5M | 0.02% | 823 |
|
|
2021
Q3 | $31.2M | Buy |
259,486
+239,789
| +1,217% | +$27.9M | 0.02% | 952 |
|
|
2021
Q2 | $2.36M | Sell |
19,697
-43,999
| -69% | -$4.83M | ﹤0.01% | 3762 |
|
|
2021
Q1 | $6.33M | Buy |
63,696
+54,085
| +563% | +$5.44M | ﹤0.01% | 2328 |
|
|
2020
Q4 | $961K | Sell |
9,611
-92,475
| -91% | -$9.79M | ﹤0.01% | 3768 |
|
|
2020
Q3 | $11.2K | Sell |
102,086
-30,960
| -23% | -$3.44M | 0.01% | 1159 |
|
|
2020
Q2 | $14.1M | Buy |
+133,046
| New | +$13.7M | 0.02% | 971 |
|
|
2020
Q1 | – | Sell |
-183,548
| Closed | -$18.3M | – | 3831 |
|
|
2019
Q4 | $18.3M | Buy |
183,548
+176,244
| +2,413% | +$16.6M | 0.02% | 909 |
|
|
2019
Q3 | $651K | Sell |
7,304
-299,435
| -98% | -$26M | ﹤0.01% | 3094 |
|
|
2019
Q2 | $25.3M | Sell |
306,739
-348,760
| -53% | -$27.3M | 0.04% | 652 |
|
|
2019
Q1 | $53M | Buy |
655,499
+649,858
| +11,520% | +$51.2M | 0.08% | 322 |
|
|
2018
Q4 | $428K | Sell |
5,641
-393,633
| -99% | -$30.7M | ﹤0.01% | 3051 |
|
|
2018
Q3 | $31.6M | Sell |
399,274
-22,688
| -5% | -$1.72M | 0.04% | 613 |
|
|
2018
Q2 | $29.6M | Sell |
421,962
-654,419
| -61% | -$47.1M | 0.04% | 656 |
|
|
2018
Q1 | $75.3M | Buy |
1,076,381
+375,805
| +54% | +$26M | 0.1% | 273 |
|
|
2017
Q4 | $48.6M | Sell |
700,576
-212,791
| -23% | -$14.3M | 0.07% | 429 |
|
|
2017
Q3 | $61.9M | Buy |
913,367
+909,229
| +21,973% | +$57.4M | 0.09% | 278 |
|
|
2017
Q2 | $282K | Buy |
+4,138
| New | +$270K | ﹤0.01% | 3066 |
|
|
2016
Q4 | – | Sell |
-846,543
| Closed | -$48.1M | – | 3320 |
|
|
2016
Q3 | $55.6M | Buy |
846,543
+537,473
| +174% | +$35.1M | 0.09% | 224 |
|
|
2016
Q2 | $18.7M | Sell |
309,070
-207,641
| -40% | -$12.1M | 0.04% | 569 |
|
|
2016
Q1 | $29.1M | Buy |
516,711
+142,678
| +38% | +$8.57M | 0.07% | 333 |
|
|
2015
Q4 | $25.4M | Buy |
374,033
+65,475
| +21% | +$4.29M | 0.05% | 485 |
|
|
2015
Q3 | $19.6M | Sell |
308,558
-68,663
| -18% | -$4.52M | 0.04% | 576 |
|
|
2015
Q2 | $24M | Buy |
377,221
+20,512
| +6% | +$1.4M | 0.05% | 535 |
|
|
2015
Q1 | $24.4M | Sell |
356,709
-722,335
| -67% | -$50.2M | 0.05% | 567 |
|
|
2014
Q4 | $75.9M | Buy |
1,079,044
+904,479
| +518% | +$64.8M | 0.16% | 122 |
|
|
2014
Q3 | $12.5M | Sell |
174,565
-118,674
| -40% | -$8.69M | 0.03% | 746 |
|
|
2014
Q2 | $21.8M | Sell |
293,239
-100,042
| -25% | -$7.23M | 0.06% | 438 |
|
|
2014
Q1 | $25.5M | Buy |
393,281
+347,681
| +762% | +$22.5M | 0.07% | 352 |
|
|
2013
Q4 | $2.71M | Sell |
45,600
-118,599
| -72% | -$6.44M | 0.01% | 1599 |
|
|
2013
Q3 | $8.53M | Sell |
164,199
-131,245
| -44% | -$6.59M | 0.03% | 779 |
|
|
2013
Q2 | $14M | Buy |
+295,444
| New | +$15M | 0.04% | 463 |
|
Other funds holding AZN
EP
IA
Israel Englander's AZN Position: Q2 2026 in Review
Israel Englander reduced its AstraZeneca (AZN) stake by 55% in Q2 2026, selling an estimated $136M and leaving 581,913 shares worth $110M. The position accounts for 0.04% of the portfolio, ranked #468.
Israel Englander first reported a position in AZN in Q2 2013 and has held it in 50 quarters since. The position peaked at $257M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Israel Englander held 581,913 shares of AstraZeneca worth $110M as of Q2 2026.
- Israel Englander sold 720,732 AstraZeneca shares in Q2 2026, an estimated $136M.
- AstraZeneca made up 0.04% of Israel Englander's portfolio in Q2 2026, its #468 holding.
- Israel Englander first reported a position in AstraZeneca in Q2 2013 and has held it in 50 quarters since.
- Israel Englander's AstraZeneca position peaked at $257M in Q1 2026.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.